Enabling Genomics in Practice.

Human Genome Complete

Washington University in St. Louis plays a crucial role in the mapping of the first human genome.

Washington University creates a CAP/CLIA lab for NGS testing. The Genetics and Molecular Pathology departments collaborate to develop Clinical Genomics Workspace (CGW), a groundbreaking software platform for clinical genomics.

More than 50 laboratories visit Washington University to learn how to operationalize clinical NGS testing.

Washinton University performs a technology transfer, Pierian is officially established, and our first office is opened in St. Louis, Missouri, USA.

We secure Series A funding after two releases of CGW that offer multi-tenant and exome sequencing support.

We open a second office in Pune, India, to support software development and large-scale biocuration efforts.

We reach 40+ customers supported by 70+ medical, scientific, and technical experts.

An agreement is finalized with Illumina, our first assay partner, and we prepare for a collaboration launch to deliver optimized interpretation and reporting solutions for Illumina pan-cancer profiling assays.

We close $27 million Series B funding to support growth in global markets.

We exceed 100 customers due to rapid expansion into Europe, the Middle East, and the Asia Pacific regions.

We secure $47.5 million in additional funding to drive expansion across new assays, new customer segments, and new geographies.

Velsera is founded in January 2023 through the merger of three leading precision medicine companies – Pierian Dx in the clinical diagnostics space, Seven Bridges in the life science analytics domain and UgenTec in the clinical laboratory automation industry.